Search
forResearch 8 of 46
- Case of alemtuzumab-related alopecia areata management in MS
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
- Mycosis Fungoides in Elderly Adults—A Diagnostic Challenge
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →